Armata Pharmaceuticals
ARMP
21 hedge funds and large institutions have $1.48M invested in Armata Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
203% more capital invested
Capital invested by funds: $488K → $1.48M (+$992K)
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.05M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$91.3K |
| 3 |
VF
Virtu Financial
New York
|
+$35.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$16K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$12.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$65K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 3 |
Renaissance Technologies
New York
|
-$16.5K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$5.07K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.08K |
ARMP Hedge Fund Activity: Q1 2018 in Review
21 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q1 2018, worth a combined $1.48M — up 203% from $488K a quarter earlier.
Fund positioning in ARMP was balanced in Q1 2018: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.05M. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $65K sold.
- 21 institutional investors held Armata Pharmaceuticals (ARMP) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $1.48M of Armata Pharmaceuticals stock for Q1 2018, up 203% quarter-over-quarter.
- 5 funds opened new Armata Pharmaceuticals positions in Q1 2018 and 5 closed out, a net change of 0 holders.
- The largest Armata Pharmaceuticals buyer in Q1 2018 was Sabby Management, an estimated $1.05M added.
- The largest Armata Pharmaceuticals seller in Q1 2018 was A.R.T. Advisors, an estimated $65K sold.
Based on aggregated 13F filings for Q1 2018.